-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Lsv9yHjp1nKO14KmCN/PTEBNmX9Z8AfnJEXUe9lZFDAvsS4CsbM5hMHqJ+jCXW4z
 Nfw5B1QRRL1zEW+TXbq7OA==

<SEC-DOCUMENT>0001096906-08-001335.txt : 20080902
<SEC-HEADER>0001096906-08-001335.hdr.sgml : 20080901
<ACCEPTANCE-DATETIME>20080715145856
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001096906-08-001335
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20080715

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UTAH MEDICAL PRODUCTS INC
		CENTRAL INDEX KEY:			0000706698
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				870342734
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		7043 S 300 WEST
		CITY:			MIDVALE
		STATE:			UT
		ZIP:			84047
		BUSINESS PHONE:		8015661200
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<html>
  <head>
    <title>utahmedicalcorr071508.htm</title>
<!-- Licensed to: a-->
<!-- Document Created using EDGARizer 4.0.6.1 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">
    <div style="TEXT-ALIGN: center">
      <hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
      <hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
    </div>
    <div style="TEXT-ALIGN: center">&#160;</div>
    <div style="TEXT-ALIGN: center"><img src="logo.jpg" alt=""><br></div>
    <div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="center">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">July 15,
2008</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">David
Burton, Staff Accountant</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Division
of Corporation Finance</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">U.S.
Securities and Exchange Commission</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Washington,
D.C. 20549-0306</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">VIA
FACSIMILE [202-772-9218] and U.S. Certified Mail</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Re: Utah
Medical Products, Inc.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Form 10-K
for the year ended December 31, 2007</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Form 10-Q
for the quarter ended March 31, 2008</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">File No.
001-12575</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Dear Mr.
Burton:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Thank you
for your review of Utah Medical Products, Inc.&#8217;s (UTMD&#8217;s) June 25 response to
the SEC comment letter dated June 6, which UTMD received June 16, regarding the
above referenced disclosures.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">From your
letter dated July 14, it appears that UTMD&#8217;s responses regarding the SEC
comments were satisfactory to the SEC.&#160;&#160;However, you have indicated
that you have an additional comment.&#160;&#160;I am baffled by that input,
because as I read your three page fax, I do not see any additional comments
related to the above referenced disclosures.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">With
regard to the request at the end of the letter that UTMD acknowledge three
statements, we admit that we only acknowledged the first two of
three.&#160;&#160;I tried to explain UTMD&#8217;s perspective on that in the June 25
response letter.&#160;&#160;For ease of reference, I have copied that response
below:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">In
connection with responding to our comments, please provide, in writing, a
statement from the company acknowledging that:</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">&#183;&#160;&#160;the
company is responsible for the adequacy and accuracy of the disclosure in the
filing;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">UTMD
Response</font>:&#160;&#160;UTMD understands that the Company is responsible for
the adequacy and accuracy of the disclosure in the filing.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">&#183;
staff comments or changes to disclosure in response to staff comments do not
foreclose the Commission from taking any action with respect to the
filing;</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Response</font>:&#160;&#160;UTMD
understands that staff comments or changes to disclosure in response to staff
comments do not foreclose the Commission from taking any action with respect to
the filing.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">&#183; <font style="DISPLAY: inline; FONT-STYLE: italic">and the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any
person under the federal securities laws of the United
States.</font></font></div><br>
      <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div id="FTR">
          <div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
        <div id="PN" style="PAGE-BREAK-AFTER: always">
          <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160;
</font></div>
          <div style="WIDTH: 100%; TEXT-ALIGN: center">
            <hr style="COLOR: black" noshade size="2">
          </div>
        </div>
        <div id="HDR">
          <div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman">&#160;
</font></div>
        </div>
      </div><br>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Response</font>:&#160;&#160;This
last statement is somewhat confusing, as UTMD clearly relies on SEC staff
comments to represent what it needs to do to satisfy SEC disclosure
requirements.&#160;&#160;Consistent with prior responses to SEC comments, UTMD
is unwilling to acknowledge this last statement, as we believe it may also
represent a violation of UTMD&#8217;s Constitutional rights.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Very
respectfully, UTMD believes that the third bullet point acknowledgement may be a
violation of its civil rights under the U.S. Constitution, in particular
Amendments Number IX and X.&#160;&#160;If you disagree, please identify what law
or regulation requires UTMD to acknowledge it cannot use SEC comments as a
defense in any proceeding initiated by the Commission.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">This
issue of not acknowledging your third bullet point is hopefully moot, assuming
that SEC concludes UTMD is substantially in compliance with applicable SEC
regulations. If SEC concludes otherwise, please provide further comments so that
we can make the necessary corrections to our public disclosures to get into
compliance before you consider consuming dear taxpayer funds going to
court.</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Please
understand that the purpose of our response is to fully comply with all
applicable U.S. laws and regulations. We look forward to continuing to work with
the SEC in these respects.&#160;&#160;Please feel free to contact me directly at
the numbers listed at the end of this letter.</font></div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Sincerely,</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">/s/ Kevin
L. Cornwell</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Kevin L.
Cornwell</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Chairman
&amp; CEO</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Direct
tele no. (801) 569-4190</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Direct
fax no. (801) 566-1328</font></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
      <hr style="COLOR: black" noshade size="2"> </div>
  </body>
</html>


</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo.jpg
<TEXT>
begin 644 logo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`!
M````/@```!L!!0`!````1@```"@!`P`!`````@```#$!`@`0````3@``````
M``!@`````0```&`````!````4&%I;G0N3D54('8T+C`P`/_;`$,``0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`?_;`$,!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`?_``!$(`&``
M4`,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/Z"?A7X$^"/CO\`X)Q_LF?M)^(OV8OV3I_B]\:?%/[$.F^._$:_
MLR?!-;:_7X]?M1?!CX7_`!$FMM(?P6^FVEUJ7A;QQK]O92QP$V%]<PWUL!<V
M\3#QSPM\%?@_\'OBW_P4`U#XL>&_@S\5_`'[&,GP=TKP+X!\0_LC?L3>$X_B
MQXG^-GP.T+Q#X:\+^)O$7@;]G'PUK=CK&J_%KQ?H/AWPA=:!J&B6,'VG3K3Q
M!;:O"U[<2Q^%OVK_`-C?X-?#3X&>++OP3^WGIO[,?CWQ-JWQO_97_9X\2G]F
M'6OA9>^-O!W[0O@30[;3/!T7AWXAWGQ6T:S^'WQ5^*'A[XF>`_`OQH^*.G_"
MWPM8Z5:7'@W3K?4/`_@_PKIGU%+\7/V6T_::^(\TGPQ_:5B_:T\6?M=?"2PU
M/]F6]OOA9<W7Q`^)OPR_9*DUKX?>*X+S0O'FO?"R#X/^"_@EKEC\9=<U?7OB
M?I]]X9\>^%O"4]YI,'CR7P9X)\2@'Q-\._B+\`)OA5^Q#+XR_9._96\;_%6#
M_@H3\2?V&OVRK3X,_L:?#KQ?/X]NOAW^R5^UI\6?#WC3X<^"-*\#ZIXBT31?
MBO;^`O@%^T)IZZ1;+=Z!X#\5W>EW?DZ7#JL:_;_[/O@;]E#XV?ML_M4_"&/]
MB?X*>&OAA\(?V;OV-/'7A30?B/\`L6^!_AEXH/CCXQ?$?]MG1/'^O6\7BWX>
M:1XAUOPSJNA?!SX:V&E3O"^DV6JZ'X@@L3'?R:PE<S\9/&W[)?PO_:WB^,OQ
M3^%/[1WAO]JRT^,W['OBS0O@GX:UWX87NA?$_P`:_$VR^-'_``3T^#GQQ\(S
MWWC?2/!.N:3%IG[37B7X7?%:ZU?QSX5\4>';+PO\+-2\3>"+6SLO`=YXN]D\
M0_M@?L\_`?\`:B^)'C;XJ_"#]HGX3_M%_%SP9^Q'\%E\'^+%^$^NV_Q"^%&I
M_M;^(?@%\*OB%\/[CP!\6O&?@S^P_AY\<_VUKFS^-*:GXMTSX@:+X;U_PMJ5
MMX#U2&X\-IX@`/(M;@_8T^'/[='COX,?%C]D+]C?PE^S<WPETVU\"?%34?@3
M\)-/M](_:*^'/@_Q+\>/C+X$\8:E<^$4MH$\2?LV^)O"/Q'\"QB58[;2_@M\
M8;N^:-IM,2X_/2#Q7\//BE\<?AQ\,/$?[,'PL_9OTW6OCK^VKX.\4^'_`(*?
ML#_![XW_`!@T?PI\+OA5^RG\7OV?='\1>$]0_9T^,M_I/B&7P%^T#::K\4VL
M?"3V.F^)=2FTBU\0_P!DZ?IEY=_KI^V9;_L1_#36KGP9^TEX%\;?$_5/VDOC
M7X#_`&J?!G@^RLK+Q)/XD^/OP.US]CK]F[X7_#SX>Z>-5T*\M]8\<:MJOPIT
MC_A&M1=O`NL>'=2^,=Y\4/%/AWP!?:W#-X3\<OAGX=^%7C3X[_MW:]^SQ^WE
M\+?&/@3_`(3G]HOQAXP^#GQ%_8B\1Z?!HNM?LT_#'X6?%6?P[X:^)7Q,O-.D
MNM,^&7[(7PRMO%>BOH]WJK^*M0L=3\$ZSX@LM9UR700#R3X?_LL>'_BOI7_!
M0#Q=X9T+]G#POXE_9;_:#\<_"OX3>$_%?[%G[(E[\'-8TCP%^SO\$?BA8R?%
MG3(?@KH'Q9F;Q#XH\=>((O%%WX9^+W@Z72])FMX]'M].FT[,_P`U_`#XK_"O
M]K#XS?!SX2>$OV/_`-DWX2Z?^U*WP8^)6DZ[=?LM?!+7O$?P-^#VI_\`!.WX
M'_M8_$?PGX9CU;P'_8?B7XF^(/B1\6])\->&/$7CS2M>T#P]X;E\2:U+X1\0
MG2=-T=ON;P-8_#7XF>+/BO\`!OP_\._V[ELOVF=/^&'[4O[3?P0U+XA?LE>%
MXM=^'7[1]I8_`/1/B3K7BSP+X\G^(B>&_'&B_`[Q`WCGP5\*_B]I>IZ3X?\`
MA_XI;5?#VE7?C+PAX<\?^G_M??#O]C/]EC6++XG>)O#_`,9O"/CCQCXF\7?'
M+X:^,O@(_@VPUWX,Z_\`L=_L/^*X-3M_A_IWB"?2_#.G>'_$'[-WPFUWX>/\
M/?$6B>-O`'C34]9M])\6:%8Z%+'J6B`'E/[97[.GPE_9,_9Q\3Z;\./A1^RC
M\6?VD/B7XGUBU_9WU7XY_LM_LT:)I^E?\(UX&E\>Z]H/C?\`X5;\)?!.AWVC
M7=OX+\2>&=!\7)X.L!IWB_XD_#KP_KBWA`U;4M']FV+]CK]I#]J7X;+\-OV6
M_P!EG_A0/Q0_X)W_``M_:S\(:?)^S=\';7Q/I/C7QM\7-?\`#TR:IJL?@]-5
MT_5="T>PMM!UCP]++&-&\1:9?QS00:A#.J_1WA+X[?LN^"/"/PR_;B\3?'OX
MK?%;PKX_TCXE_#O3?B;\31X0TRT^#&BZ=X0\0?%_XV6'C;P1X=\(?#./X6WO
MA.W_`&7O^$<^*?AE?"3>*_#GC;P%!H^O^&K;Q"WB[4Y/'OV8?V9_!\?Q$\,_
M&GX)?#G]M;]GSPE\:?#WQ$U71/%E]XG_`&96\/\`AWX>_%3XK^*OVI)?".M_
M#'Q0/'7Q$^%GA;QA\0?'7B;7/!.B:!H?_"7^$8?$G_"(^-5^'\EO;Z+IH!\&
M6_P6_9!TO_@G'HW[.5_\>OV6[S]JNT@^'OA?Q%XYU[XRZSKUCI'A+0?VK_`O
MQK\=^#?!7BO78K_6?`WAK6]!\&P7%YX8\&:/X9T36/%FDZ)+J5D)]/L]5M.J
M^'<'P2^`GQ;^&/C'X:?M+?LG>*_"W[+'Q<^-?B/X.2>(OBVFB?$#XT?!']JC
MP%INE?$[P7\9/%:^&M:O+WX[?!GQAX0\%1?#OXS>)[CQC>_&3X:^'M'\*_$[
M5?#?BZZUSXCM_3;7R+^VW^W-^S5_P3U^!'B+]H?]J+X@6G@?P+HI-CI&GP(F
MH^,?'WBB:WFGTSP1\/O#*30WGB;Q7JP@E-O9PO!8Z=9Q7>M^(-2T;P]IVJ:O
M9`'XB_M9:_\`#K]ICXV>#?VK8_VA/V6=#\6_![Q5^R-IWPC^"][\<;%+BZ^'
M7PG_`&R/A+^U3\>=<\?>/++PW?Z+8^-_&_\`PJ3P=X4^'_A30;+Q'X?\.VWA
MB?6-3\:7EUXZO-(\'ZO[5-]\+OVP/'L?[0?B3]I_]D'X:?$GX->#OA)IG[,_
MPP3XV:CXO\.:GXA\`?MB_LW?MF>,KWXS^/[3P)H5QX>L_B'K_P"RO\,/A;IV
MG^#/"/CD^!="?Q+XY_M7Q7J&MV_@_1/Y-_VP_P#@[[_X*5?%GXP:OK7[)&I^
M#_V4_@E8/<:?X2\$S?#WX;_%CQIK6GI<%K?Q#\0/%/Q%\+>)K0>(KN,;CI7@
MS3]!T'2+>1--8^(+JU?Q!?\`RI_Q%3?\%P_^CMO#O_B.'[-/_P`Z6@#^YO\`
M:6^)7PZ_:T\=_!/]H:Z_:"_9/^#WQ0_9'UKP[XW^`OPXU_XZ1^,O#_C[QA-\
M2OA[XO\`BCHWQ4\7>'/!P_X0WPKXC\'_``UL?`_@3Q!X7T3QMKF@:IXGU'Q[
MK?A>Y?0+#P;JGU/\;?VT_A!^TC^RM^U=\']4^*W[-GPO\1_%;]G3XG?"[X>)
MJ/[0>D>*FO/&WQ"^&_C/PK._B=M$\)PZ=X>\):;JVIZ!_9FM6.J>(M:UBSN=
M8N-2\*^&9-*L;;6_!O\`@VM_;M_:>_X*'?\`!/?Q/\>/VM/B!9_$CXH:;^TK
M\1_AW9^(+'P;X*\#0Q>$O#_@OX7ZQI.FG1O`>@>&]$D>VU#Q)K$S7TFGM?SB
MZ6*>YDBM[=(L'_@YM_;N_:I_X)Y?\$_OAY\;_P!D#XH)\)?B?KO[5GP\^&NJ
M^)7\$?#SQ\+KP5KOPP^-/B+5=&_L7XF>$_&6@0&ZUCPCX?O/[1M]*AU6#[`;
M>WOHK6[O8;D`I?M!^*/V;?B[I_[/N@:)\5/V5_"OQ4^"OP_^!&E?#C]M7PM^
MT;?>#OC#\&M<\*>*=*O/C)X;CTOP]X7L=9\:_#?7/#'AS3%T/P!?>*M2\#?%
M'6-7UG1/B3X?\&Z39V?B.]]*_P""CGQ(_9Z_:LT7X=Z?\,?VJOV;;:?PKX-_
M;`T#4SXJ^)EOI4;7WQU_8U^-OP$\%-:M9:=JQE@A\;_$+09]<D=8FL=!CU"_
MMH[^ZMXM/N/\_P`_XBD?^"Z7_1[<'_B-'[(W_P`X:OK']CC_`(.[_P#@IW\'
M?B[INM_M9>)_"_[7WP8U"2TL/%7@6^^'/PH^$7B[1M.^T;KO7/A[XN^$W@3P
M;!%XCBB8'[#XVTSQ3H&HP0FPC@T.ZN1KEH`?UF_MU_!K]C[]I?QSK)^$7[=G
MP-^%7P<_:1@^+.E_MF?#&?Q/8W>DZ[XI\:?LM?&KX"^#?VE_A196UQ':Z%\;
MM(;XAZ+X>^)>FSO9>'/B]X,T[1-3\17-MXK\!:9=>(/N7P7_`,%);^P\!>$?
M#>K:U^Q9XA^*.B6GA3P_XHU2Q_:YE\/_``]\8WB:KHFB:OXA^'Z1?!?Q!XJL
M8[O1GUCQ3'X8\5^']$?2;^&R\(6>M>)(YF\2I]>_L*?M]_LP_P#!1OX$Z+^T
M#^RWX_M_%_A2^:*P\2^'=02#3/'OPU\4_9TN+SP7\1O"RW5U<>'/$=BK[E`G
MO-'UJR,.M>&=7UO0;RQU6Y^S:`/#_P!I3]HKX3?LE?`?XI?M(?'/Q-#X2^%7
MP@\)ZAXO\7ZS(JS7/V2S\N"RTG2+,R1/JGB+Q%JMQ8>'_#.C0.+K6O$&IZ;I
M5KFXO(@?\;W_`(*P?\%3/CQ_P5;_`&G-<^-OQ3OK[0/AUH5QJ>B?`?X+6^HR
M77ACX1>`);F,P6-O&HBMM4\9>(4M+/4_'_C"2WCO?$>LQQ00)I_AK1_#6@:+
M_3[_`,'G/_!0_4]9^('P>_X)J_#[7)(?#7@W2M)^/?[0L=A<E5U;QEX@CO;7
MX2>!]56-HY5C\+>&!J7CZ_TZX%Q8:C+XW\$:FJI?>'X63^$2@`HKV?5_V?\`
MXJ:!\!/!7[2^M^&I]*^$/Q'^)'C/X5>`_$=\6@;Q9XL^'FB>&]=\;+HMJR>9
M=:3X=M_%WAZRO=7#+92:O?3Z59275[I.M1:=XQ0!_J4_\&:G_*)?QK_V>7\8
M?_5<?!*L3_@]`_Y13?"7_L^;X3?^J5_:-K;_`.#-3_E$OXU_[/+^,/\`ZKCX
M)5B?\'H'_**;X2_]GS?";_U2O[1M`'^7C117KVB_`GXG^(_@AX]_:)T/PS=:
MI\)_A?X_\`?#7X@>)+/]^OA3Q/\`%'2?&>L>!$U>V13-;:9X@A\`^)[.WU=A
M]@AU:TL]*NYH+[6-'AO@#["_X)=?\%-OC[_P2P_:=\.?'[X,ZG<:GX9O9]/T
M3XT?"*]U">V\)?&+X="[,FH>'-9B02PV6O:='-<ZAX'\6QVT]_X3U\I=)#?Z
M/>:[H6L_[)W[*O[3GPC_`&R_V>?A1^TY\"O$`\1_"_XP>$[+Q5X<O)!#'J6G
M/*TEIK/AGQ!:03W,>F^*?"6NVNI>&?%&E"XG_LS7])U&R$\RP"5_\)&O[H/^
M#,;_`(*#ZKX9^+?QB_X)O^.]>EF\(_$S1=5^.WP%M+ZX9X]'^(OA*UL[?XH^
M%-'1W>14\8^"([3QF+.-8[&RD^'.OWR*M[KEV]P`?RQ?\%6_V@M0_:E_X*2_
MMM?'.^OGU"V\9?M%_$JS\,W$DAE=/`/@S7KCP'\-[,R'AAIW@#PQX:T]2H";
M;4"-53:H^(?!GA'7_B!XP\*>`_"E@^J>*?&WB70O"/AK3(B!)J.O^)-4M=&T
M>PC)X#WFHWMM;H3P&D!K%O[Z[U2^O=2OYGN;[4;NYOKRXDY>>[NYGN+B9R,`
MO+-([M@#EC7Z'_\`!'_0M+\2?\%5O^"<VD:UY+:=-^VI^S==317"+)!<R:9\
M5_"^J6ME+&S*KI?7=G!9LC95A/M*2`[&`/Z?_P#@ZP_98\"?L2?\$^?^".W[
M*GPXM[>+PO\`!-/C9X/%]!`+9O$?B&+PI\)K_P`9^,[V)<`:KXW\8WVO>+M7
M*A4;4]:NRB1QE8U_AFK_`$/_`/@^%AF;X1?\$]+A8I#!%\1_VA(9)@C&*.:?
MPQ\*W@B>0#8LDR6]P\2,0SK!*R@B-R/\\"@#_4I_X,U/^42_C7_L\OXP_P#J
MN/@E6)_P>@?\HIOA+_V?-\)O_5*_M&TW_@S&\3:#J?\`P2S^*?AJQU2SN-?\
M,?MD_$N77M(2>,ZAIEMKOPO^#%UHUY<VN[SH[+5([6^2PNV06]U/IVI6\,CS
M6%TD6!_P>F^*O#^G?\$R_@-X/N]4M(O$WB?]M;P+J^B:*TT8U"_TCPM\%_CK
M%XAU6"V9Q+)8:1<^(O#UG?W,:.EO=:[I4,NTWD9H`_S$J_N#_P"#4']ECX?_
M`+;7[$7_``69_95^)UM#+X1^-FB_LY>#YKV2WCNIO#FNS:)\?KWPAXSTV&4%
M#K/@CQ;9:)XNT5G!1-5T6S9U>,,C?P^5_H4?\&.EK<)X!_X*/7K0NMI<>,/V
M7[6&<C]W)<6>B_'66ZA4]W@COK1W&.%N(^N>`#^`CXB>!/$OPM^('CGX8^,[
M$Z7XP^'/C'Q-X$\5Z8Q+-IWB7PAK5[X?UVQ+,J,QM-4T^ZMR2BDF/)53P/LO
M_@E;\?;[]E__`(*/_L3?'*SO'L;7P3^T?\+X_$LT<GE/)X#\5>)+/P7\1;(2
M;D5/[2\!>(O$>GEG)B`NCYRO%O1O0_\`@M;I&DZ)_P`%;O\`@HO8Z+'%'92?
MM=?&K5)$A:-D&IZYXRU'6];/[L!5=M:U#4&DCQNBD+QR9=&-?F587UUIE]9Z
ME8S/;7NGW=O?6=Q&<2075I,D]O,A[/%-&CJ>S**`/I3]MCX.7W[//[8O[5'P
M*U&T>SN/A%^T-\8OAY'"R[%>Q\*>/]?T?3+N#@![._TVUM+ZRF7]W/9W$$T9
M*2*3Q?[-GQBU#]G?]HKX"?'_`$F"2ZU3X'?&CX7?%_3K6)Q')=7OPU\<:'XR
MMK5'8A5:YFT5(07(3Y_F^7-?T[?\'@7["VI_`+_@H)H?[7?AS1I(_AA^V7X0
MT^_U74+:W":?I?QO^%VD:1X.\9Z1*L"&&T?Q!X/MO`OC&WFN&BGUW6=1\97$
M4<S:9?3U_(_0!_JT_P#!S;^S#;_\%#O^"/%A^T#\`]OCV[^!EUX)_;#\`7V@
MQ/>7'C+X)ZQX+U"W\<3:0$5C)8+\//&%K\3YPJB>>T\"I!;[YIEMY_\`*6K_
M`$-/^#4;_@M3X*\3?#G0/^"57[5'BC3=+\6^'#?Z=^R5XK\5W,"Z1\0/!^KS
MW-Y??`'5+S46,!\5:!>7=]+\.+2[D>#Q-X7O6\#:?%:W_ACP_I_B+XW_`."Y
M?_!K%\7?AAX\\;?M2?\`!,[P#??%+X)>)[_4/$_C#]E_PG;F[^)7P@U&]DEO
M-3_X5/X?C_TCXA?#B2Z>1M)\(Z"MQXX\)+/;Z1INB>(]!MGU+20#^6#]BS_@
MH3^V1_P3R\=ZQ\1/V/?CIXG^#FO^)K&STWQ;96%GH'B7PCXPL-/DN)=.M_%O
M@7QGI'B+P;XADTM[V_.CWVIZ'<:EH9U#4'T:]L)+ZZ>6M^V?^W]^U_\`\%"?
MB'IGQ/\`VP/C?XF^,GBG0-.GT?PO%J5GH/AWPOX1TJ[FBGO+'PEX(\':3X>\
M'>&TU":WM9=6N-(T.TO=:EL[.?6+J_GM8)4^4M?\/Z]X4UK5/#?BG1-7\->(
MM$O9].UK0-?TV]T;6M(U"V<QW-AJFE:C#;7UA>V\@*3VMW!%/$X*R1J1BHM'
MT;5_$.JZ?H6@:5J6N:WJUW!I^E:/H]C=:GJNIW]U((K:RT_3[**>[O;NXE98
MX+:VAEFED8)&C,0*`,VO]4K_`(-=?V:;;]@;_@C]XA_:7^.Y7P(WQ\U/QI^U
MEXLU'78FLY?"OP$\)^#K6Q\#ZAJBL!C3;OP?X6UWXHV$^69]$\<VA8(ZF)/Y
M\/\`@B!_P:T?&[X[>//!7[2O_!2'P!K/P9_9S\.WUCXET+]GKQ?;W&C?%OXX
MW%JR76GZ?XV\-R>5JWPP^&TETB'Q#:>)(]-\>>)K&&;1].T/1-,U:#Q=!]^?
M\'6__!9OP)X(^%VK?\$H?V4O$6DW7BOQ!%I6E?M5Z[X.EMHM$^&G@+1'M;K2
MOV?])ETLQVMOXF\03V6FR>/=-LFCMO"_@ZQC\$W]O<77BO6+'P^`?P??M1?&
MW4OVE?VEOV@_VB=8@EM=3^.WQK^*/Q?O+*9E9[";XC>-M;\7'3OD>1%33UU=
M;**.-VBCB@2.(^6JUTO[%7P;O_VA_P!L+]EKX$Z;:R7ES\7OVA/@_P##MHHT
M+B.R\5^/M!T?4KN;@B.TL-.NKN^O9W'EV]G;3SRD1QL1\R5_6U_P9_\`[#.H
M?'__`(*$ZW^UGXCT=YOAE^QEX.OM6TV_N;=WL-2^-GQ0TO6/!W@?28A(JV]S
M)H7A2;QYXQFEB>:;1=7TGPG/)!&VI6=P@!_?K_P5>_X)T?#[_@J)^Q9\2_V7
M/&<]EH7B>^2'QE\&/']W:O='X;?&3PW:WP\'^*6CA5KB32+E+_4?"_BVTME-
MU?>#?$7B"TLF@U"6SNK?_&4_:$_9_P#BW^RQ\:?B-^SY\=O!NI^`?BO\*_$M
M[X6\8^&-5C*RVM]:[9+>^L+E0;?5=!UO3YK36O#FO:?)/I>OZ#J&G:SI=S<Z
M??6T\G^\97X%_P#!;O\`X(0?!+_@K?\`#ZW\7:+>Z1\(?VQ?A_H4NG?#'XU-
M82R:3XFTB![F\MOAG\7K33HWOM9\%3WUQ/)H^O6D-YXC\`7][=:IHEOJNFW>
MN>%?$`!_D&65[>:;>6FHZ==W6GZAI]U;WMA?V5Q+:WEE>6LJ3VMW:74#QSVU
MU;3QI-;W$+I+#*B21NKJ"/\`8T_X-\O&/[=/Q)_X)A_`[XE?M\>-7\<_$+Q]
M#=>)/A5JVN:2]I\29?@%<6NGVWPTU'XIZV;EH_%WBOQ-9VM[XLT[Q)+90:SJ
M?@S7/"]UXHO=7\33:M?-_`;_`,$Y_P#@WR_:M^(/_!6+P7^QO^V;\$O%WPU^
M'/PH:?XS_'76KVVFD\%^._@WX+UFPMX++X=^.[`_V#XOTSXJ^);S0_`\&H>&
M]5DU/1M/U?Q%J-Q;66K>$]5TZT_UF=.T[3](T^QTG2;&STO2M+L[73M,TW3K
M:&RT_3M/LH$MK.QL;.V2*WM+.TMHH[>VMK>..&"&-(HD1$50`>(?%[]E3]E[
M]H.6&?X]_LW?`3XWS6\2P6\WQ>^#WP\^)4L$"?<AAD\9^'=:>*)?X8T*HO91
M4/PB_9,_97_9^NI+WX"_LS_L_?!&]EB>"6[^$7P:^'/PVNI89`RR0R7'@SPW
MHLKQ2*S*\;.48,P8$$U]`T4`?BO_`,'`/C#]NGX<?\$Q_CK\2_V!?&S>!OB5
M\/K6W\4?$S5-$T8W_P`1A\![2UOX/B;??"S66G$7A'Q=X9TZYMO%]YXECL;K
M6-.\(Z!XFE\+W6D^*%T?4(O\</4-0O\`5[^^U75;Z\U/5-3O+G4-2U+4+F:]
MO]0O[V9[F\OKZ\N7EN+N\N[B62XN;FXDDFGFD>65W=V8_P"^S?V%CJMC>Z9J
M=E::CINI6ES8:AI]_;PW=C?V-Y"]O=V5Y:7"2075I=6\DD%Q;SQO#-#(\<B,
MC,I_R:/^"FG_``;[?M6?"K_@JIXH_9,_8Q^!7C;XJ?#3XUN_QA_9\U#1+";_
M`(1/P9\+?$VL3VVJZ#X^\<:@T7AKP9I_PD\3?;O!]UJOBO7+26\T*+P?K$[O
MJ/B[3K&<`_`OX$?`OXJ_M,?&'X=_`3X(>#M5\??%7XJ>)].\)>"_"NCQ![G4
M=5U&0@RW$[E;;3=(TRU2XU77M;U"6VTK0=$LM0UG5KNTTVQNKF+_`&:?^"2G
M_!.3P'_P2X_8G^&G[,/A:>PUSQC")O''QM\?65L;?_A8?QD\36ME_P`)9K\?
MF1Q7']B:7#8Z9X0\'PW,<=U;^#_#>A)?K)J9OKB?X<_X(:?\$$_@_P#\$E_`
M<WQ`\:WN@_%_]M'Q]HB6'C_XMV]A(?#_`(`T6Z$4]W\-/@Y'J=O#J5AX;^T)
?&/$?BR\MM/\`$/CRZM8+B^L=$T:WT[PUIW]"%`'_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
